Subscribe
Health

Melbourne medical research institute wins $10.6m for drug discovery

WEHI has received a $7 million grant from the Australian Government's Medical Research Future Fund to expand the National Drug Discovery Centre in Melbourne. WEHI is co-investing $3.6 million, taking the total program to $10.6 million.

4 min read
Scientists operate robotic drug-screening equipment at a Melbourne laboratory
WEHI's National Drug Discovery Centre in Melbourne has screened over 10 million compounds since 2020 and will expand with $10.6 million in new funding | Digitally illustrated image
Caleb Reed
By Caleb Reed · 2026-08-26

TLDR

WEHI has secured a $7 million federal grant to expand its National Drug Discovery Centre in Melbourne, with $3.6 million in co-investment bringing the total program to $10.6 million. The three-year partnership with the Bio21 Institute and Therapeutic Innovation Australia will support at least nine screening projects.

KEY TAKEAWAYS

01A $7 million MRFF grant combined with $3.6 million from WEHI brings the total program to $10.6 million.
02Since 2020, the National Drug Discovery Centre has screened over 10 million compounds across 30-plus projects.
03At least nine nationally selected screening projects will receive support over the next three years.
04Partners include the Bio21 Institute at the University of Melbourne and Therapeutic Innovation Australia.
05MRFF grants are funded from investment returns managed by the NHMRC and the Department of Health.

WEHI has received a $7 million grant from the Australian Government's Medical Research Future Fund to expand the National Drug Discovery Centre in Melbourne.[1] WEHI is co-investing $3.6 million, taking the total program to $10.6 million.[1]

The project runs for three years across WEHI, the Bio21 Institute at the University of Melbourne, and Therapeutic Innovation Australia.[1] The funding falls under the MRFF's 2026 National Critical Research Infrastructure program, which provides Stream 3 grants of up to $7 million per project.[3]

Since opening in 2020, the National Drug Discovery Centre has screened over 10 million compounds across more than 30 research projects.[1] The centre runs ultra-high-throughput robotic screening platforms for biochemical and cell-based assays at WEHI's Parkville campus, giving researchers and small businesses access to industry-standard drug candidate identification tools.

The expanded centre is expected to support at least nine nationally selected screening projects over the next three years.[1] Access will be open to Australian researchers and small-to-medium enterprises.

Professor Guillaume Lessene, Division Lead and Associate Director of Therapeutic Discovery at WEHI, said the investment addressed a long-standing gap. "Our researchers deserve better access to the advanced tech needed to turn their promising discoveries into future medicines," Lessene said.[1]

Associate Professor Jeff Mitchell, Joint Head of the NDDC, said the centre would lift the odds of Australian discoveries reaching patients. Mitchell said it will play a critical role in ensuring first-of-its-kind discoveries made in Australian laboratories have the best possible chance of turning into treatments made on Australian soil.[1]

The Medical Research Future Fund is administered by the National Health and Medical Research Council and the Department of Health, drawing on investment returns to fund health and medical research infrastructure.[2] The three-year program begins immediately following the 26 August 2026 grant announcement.

FREQUENTLY ASKED QUESTIONS

What is the National Drug Discovery Centre?
The National Drug Discovery Centre is a facility at WEHI's Parkville campus in Melbourne that gives Australian researchers and small businesses access to ultra-high-throughput robotic screening platforms to identify potential drug candidates from millions of small-molecule compounds.
Where does the Medical Research Future Fund money come from?
The MRFF is an Australian Government initiative funded from investment returns managed by the National Health and Medical Research Council and the Department of Health, not from annual budget appropriations.
Who can access the expanded centre?
Access is open to Australian medical and academic researchers and small-to-medium enterprises, with at least nine nationally selected screening projects to be supported over the three-year program.
Caleb Reed

Caleb Reed

Caleb Reed covers breaking news and sport. He works to the rhythm of a story as it unfolds, and he is happiest when the facts arrive faster than anyone can spin them.

What's your reaction?

Make us a preferred source on Google

Tap once and our reporting shows at the top of your Google search results and AI answers. You can change this at any time.

Add as a preferred source on Google
Subscribe — it's free